Ababneh, Nidaa A, Ban Al-Kurdi, Raghda Barham, Dema Ali, Nour Sharar, Duaa Abuarqoub, Hanan Jafar, Bareqa Salah, and Abdalla Awidi. 2020. 'Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton’s jelly samples', Stem Cell Research, 49: 102000.
Abdel-Razeq, Hikmat, and Hasan Hashem. 2020. 'Recent update in the pathogenesis and treatment of chemotherapy and cancer induced anemia', Critical Reviews in Oncology/Hematology, 145: 102837.
Ashmore-Harris, Candice, Samuel Ji Blackford, Benjamin Grimsdell, Ewelina Kurtys, Marlies C Glatz, Tamir S Rashid, and Gilbert O Fruhwirth. 2019. 'Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible', Stem Cell Research, 41: 101599.
Baldari, Silvia, Giuliana Di Rocco, Martina Piccoli, Michela Pozzobon, Maurizio Muraca, and Gabriele Toietta. 2017. 'Challenges and strategies for improving the regenerative effects of mesenchymal stromal cell-based therapies', International journal of molecular sciences, 18: 2087.
Buzhor, Ella, Lucy Leshansky, Jacob Blumenthal, Hila Barash, David Warshawsky, Yaron Mazor, and Ronit Shtrichman. 2014. 'Cell-based therapy approaches: the hope for incurable diseases', Regenerative medicine, 9: 649-72.
Cho, In Ki, Carissa Emerson Hunter, Sarah Ye, Alvince Learnz Pongos, and Anthony Wing Sang Chan. 2019. 'Combination of stem cell and gene therapy ameliorates symptoms in Huntington’s disease mice', NPJ Regenerative medicine, 4: 1-9.
Debeljak, Nataša, Peter Solár, and Arthur J Sytkowski. 2014. 'Erythropoietin and cancer: the unintended consequences of anemia correction', Frontiers in immunology, 5: 563.
Eliopoulos, Nicoletta, Raymonde F Gagnon, Moira Francois, and Jacques Galipeau. 2006. 'Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure', Journal of the American Society of Nephrology, 17: 1576-84.
Fabre, Emmanuelle E, Pascal Bigey, Yves Beuzard, Daniel Scherman, and Emmanuel Payen. 2008. 'Careful adjustment of Epo non-viral gene therapy for β-thalassemic anaemia treatment', Genetic vaccines and therapy, 6: 10.
Fierro, Fernando A, Nataly Magner, Julie Beegle, Heather Dahlenburg, Jeannine Logan White, Ping Zhou, Karen Pepper, Brian Fury, Dane Philip Coleal‐Bergum, and Gerhard Bauer. 2019. 'Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions', Transfusion, 59: 893-97.
Gao, Guangping, Corinna Lebherz, Daniel J Weiner, Rebecca Grant, Roberto Calcedo, Beth McCullough, Adam Bagg, Yi Zhang, and James M Wilson. 2004. 'Erythropoietin gene therapy leads to autoimmune anemia in macaques', Blood, 103: 3300-02.
Gilreath, Jeffrey A, David D Stenehjem, and George M Rodgers. 2014. 'Diagnosis and treatment of cancer‐related anemia', American journal of hematology, 89: 203-12.
Hosseini, Ahmad, Hajar Estiri, Haleh Akhavan Niaki, Akram Alizadeh, Baharak Abdolhossein Zadeh, Sayyed Mohammad Hossein Ghaderian, Akbar Farjadfar, and Ali Fallah. 2017. 'Multiple Sclerosis Gene Therapy Using Recombinant Viral Vectors: Overexpression of IL-4, IL-10 and Leukemia Inhibitory Factor in Wharton’s Jelly Stem Cells in The EAE Mice Model', Cell Journal (Yakhteh), 19: 361.
Jahromi, Shiva Hamidian, and John E Davies. 2019. 'Concise review: skeletal muscle as a delivery route for mesenchymal stromal cells', Stem Cells Translational Medicine, 8: 456.
Johnston, Julie, John Tazelaar, Victor M Rivera, Tim Clackson, Guang-Ping Gao, and James M Wilson. 2003. 'Regulated expression of erythropoietin from an AAV vector safely improves the anemia of β-thalassemia in a mouse model', Molecular Therapy, 7: 493-97.
Kern, Susanne, Hermann Eichler, Johannes Stoeve, Harald Klüter, and Karen Bieback. 2006. 'Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue', Stem cells, 24: 1294-301.
Kim, Airie, Seth Rivera, Dana Shprung, Donald Limbrick, Victoria Gabayan, Elizabeta Nemeth, and Tomas Ganz. 2014. 'Mouse models of anemia of cancer', PloS one, 9: e93283.
Lam, Alan TL, Shaul Reuveny, and Steve Kah-Weng Oh. 2020. 'Human mesenchymal stem cell therapy for cartilage repair: review on isolation, expansion, and constructs', Stem Cell Research, 44: 101738.
Lee, K, N Lee, E Shin, J Chang, D Na, and J Lee. 2020. 'Enhancing the therapeutic potential of mesenchymal stem cell-based therapy via CRISPR/Cas9-based genome editing', Cytotherapy, 22: S15.
Lippin, Yitzhak, Michal Dranitzki-Elhalel, Einat Brill-Almon, Chava Mei-Zahav, Sarah Mizrachi, Yael Liberman, Adrian Iaina, Eli Kaplan, Eduardo Podjarny, and Evelyne Zeira. 2005. 'Human erythropoietin gene therapy for patients with chronic renal failure', Blood, 106: 2280-86.
Liu, Min, Xing Jin, Xigan He, Ling Pan, Xiumei Zhang, and Yunxue Zhao. 2015. 'Macrophages support splenic erythropoiesis in 4T1 tumor-bearing mice', PloS one, 10: e0121921.
Ma, C, Z Fan, Z Gao, S Wang, and Z Shan. 2017. 'Delivery of human erythropoietin gene with an adeno-associated virus vector through parotid glands to treat renal anaemia in a swine model', Gene therapy, 24: 692-98.
Macieira-Coelho, Alvaro. 2016. 'Slowing down of the cell cycle during fibroblast proliferation.' in, Cellular Ageing and Replicative Senescence (Springer).
Madeddu, Clelia, Giulia Gramignano, Giorgio Astara, Roberto Demontis, Elisabetta Sanna, Vinicio Atzeni, and Antonio Macciò. 2018. 'Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach', Frontiers in physiology, 9: 1294.
Majumdar, Anish Sen, Alya Zolotorev, Sara Samuel, Kimvan Tran, Beth Vertin, Melinda Hall-Meier, Beth-Ann Antoni, Emmanuelle Adeline, Mohan Philip, and Ramila Philip. 2000. 'Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model', Cancer gene therapy, 7: 1086-99.
Maruyama, H, K Ataka, F Gejyo, N Higuchi, Y Ito, H Hirahara, I Imazeki, M Hirata, F Ichikawa, and T Neichi. 2001. 'Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats', Gene therapy, 8: 461-68.
Musiał-Wysocka, Aleksandra, Marta Kot, and Marcin Majka. 2019. 'The pros and cons of mesenchymal stem cell-based therapies', Cell transplantation, 28: 801-12.
Nekanti, Usha, Lipsa Mohanty, Parvathy Venugopal, Sudha Balasubramanian, Satish Totey, and Malancha Ta. 2010. 'Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications', Stem Cell Research, 5: 244-54.
Nurgali, Kulmira, R Thomas Jagoe, and Raquel Abalo. 2018. 'Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?', Frontiers in pharmacology, 9: 245.
Osada, Shiwori, Isao Ebihara, Yasuhiro Setoguchi, Hisahide Takahashi, Yasuhiko Tomino, and Hikaru Koide. 1999. 'Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene', Kidney international, 55: 1234-40.
Roth, JC, DT Curiel, and L Pereboeva. 2008. 'Cell vehicle targeting strategies', Gene therapy, 15: 716-29.
Salamin, Olivier, Tiia Kuuranne, Martial Saugy, and Nicolas Leuenberger. 2018. 'Erythropoietin as a performance-enhancing drug: its mechanistic basis, detection, and potential adverse effects', Molecular and cellular endocrinology, 464: 75-87.
Sankaran, Vijay G, and Mitchell J Weiss. 2015. 'Anemia: progress in molecular mechanisms and therapies', Nature medicine, 21: 221-30.
Shi, Qin, JingWei Gao, Yao Jiang, Baolan Sun, Wei Lu, Min Su, Yunzhao Xu, Xiaoqing Yang, and Yuquan Zhang. 2017. 'Differentiation of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells into endometrial cells', Stem cell research & therapy, 8: 1-12.
Shirley, Jamie L, Ype P de Jong, Cox Terhorst, and Roland W Herzog. 2020. 'Immune responses to viral gene therapy vectors', Molecular Therapy, 28: 709-22.
Shomali, Navid, Tohid Gharibi, Ghasem Vahedi, Rebar N Mohammed, Hamed Mohammadi, Sevda Salimifard, and Faroogh Marofi. 2020. 'Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders', Journal of cellular physiology, 235: 4120-34.
Sironi, Francesca, Antonio Vallarola, Martina Bruna Violatto, Laura Talamini, Mattia Freschi, Roberta De Gioia, Chiara Capelli, Azzurra Agostini, Davide Moscatelli, and Massimo Tortarolo. 2017. 'Multiple intracerebroventricular injections of human umbilical cord mesenchymal stem cells delay motor neurons loss but not disease progression of SOD1G93A mice', Stem Cell Research, 25: 166-78.
Sweeney, Nathan Paul, Cathy Regan, Jiahui Liu, Antonio Galleu, Francesco Dazzi, Dirk Lindemann, Charles Anthony Rupar, and Myra Olga McClure. 2016. 'Rapid and efficient stable gene transfer to mesenchymal stromal cells using a modified foamy virus vector', Molecular Therapy, 24: 1227-36.
Wang, Chuan, Ying‑Ge Chen, Jian‑Li Gao, Gui‑Yuan Lyu, Jie Su, QI Zhang, Xin Ji, Ji-Zhong Yan, Qiao‑Li Qiu, and Yue‑Li Zhang. 2015. 'Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model', Oncology letters, 10: 754-60.
Wang, Zhuojun, Shulin Li, Yanping Wang, Xiangyu Zhang, Lu Chen, and Dong Sun. 2019. 'GDNF enhances the anti-inflammatory effect of human adipose-derived mesenchymal stem cell-based therapy in renal interstitial fibrosis', Stem Cell Research, 41: 101605.
Wei, Wei, Yong Huang, Dan Li, Hong-Feng Gou, and Wei Wang. 2018. 'Improved therapeutic potential of MSCs by genetic modification', Gene therapy, 25: 538-47.
Wyrobnik, Tom A, Andrea Ducci, and Martina Micheletti. 2020. 'Advances in human mesenchymal stromal cell-based therapies–Towards an integrated biological and engineering approach', Stem Cell Research, 47: 101888.
Ye, Fei, Jinghua Jiang, Chen Zong, Xue Yang, Lu Gao, Yan Meng, Rong Li, Qiudong Zhao, Zhipeng Han, and Lixin Wei. 2020. 'Sirt1-overexpressing Mesenchymal stem cells drive the anti-tumor effect through their pro-inflammatory capacity', Molecular Therapy, 28: 874-88.